MAPT and neurodegenerative disease: The specific increases of plasma p-tau212 in autopsy-verified AD patients and in AD but not in other neurodegenerative diseases, indicate that the molecular events that lead to the availability of tau hyperphosphorylated at this site in the blood is exclusive to AD.